Logo image of ISPC

ISPECIMEN INC (ISPC) Stock Price, Quote, News and Overview

NASDAQ:ISPC - Nasdaq - US45032V2079 - Common Stock - Currency: USD

1.75  -0.06 (-3.31%)

ISPC Quote, Performance and Key Statistics

ISPECIMEN INC

NASDAQ:ISPC (2/21/2025, 11:32:40 AM)

1.75

-0.06 (-3.31%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High11.8
52 Week Low1.76
Market Cap1.68M
Shares960.00K
Float820.00K
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO06-17 2021-06-17


ISPC short term performance overview.The bars show the price performance of ISPC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

ISPC long term performance overview.The bars show the price performance of ISPC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ISPC is 1.75 USD. In the past month the price decreased by -20.96%. In the past year, price decreased by -80.54%.

ISPECIMEN INC / ISPC Daily stock chart

ISPC Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 36.28 36.81B
DOCS DOXIMITY INC-CLASS A 57.05 13.70B
WAY WAYSTAR HOLDING CORP N/A 7.27B
CERT CERTARA INC 33.94 2.13B
TDOC TELADOC HEALTH INC N/A 2.05B
GDRX GOODRX HOLDINGS INC-CLASS A 15.06 1.84B
SDGR SCHRODINGER INC N/A 1.67B
PHR PHREESIA INC N/A 1.66B
EVH EVOLENT HEALTH INC - A 16.67 1.28B
HSTM HEALTHSTREAM INC 50.63 1.00B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 969.28M
DH DEFINITIVE HEALTHCARE CORP 14.85 782.65M

About ISPC

Company Profile

ISPC logo image iSpecimen Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Lexington, Massachusetts and currently employs 53 full-time employees. The company went IPO on 2021-06-17. iSpecimen Inc. is a technology-driven company. The firm's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The firm's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.

Company Info

ISPECIMEN INC

450 Bedford St Ste 1010

Lexington MASSACHUSETTS US

CEO: Christopher Ianelli

Employees: 53

Company Website: http://www.ispecimen.com/

Investor Relations: https://ispecimen.irpass.com/

Phone: 17813016700

ISPECIMEN INC / ISPC FAQ

What is the stock price of ISPECIMEN INC today?

The current stock price of ISPC is 1.75 USD. The price decreased by -3.31% in the last trading session.


What is the ticker symbol for ISPECIMEN INC stock?

The exchange symbol of ISPECIMEN INC is ISPC and it is listed on the Nasdaq exchange.


On which exchange is ISPC stock listed?

ISPC stock is listed on the Nasdaq exchange.


What is ISPECIMEN INC worth?

ISPECIMEN INC (ISPC) has a market capitalization of 1.68M USD. This makes ISPC a Nano Cap stock.


How many employees does ISPECIMEN INC have?

ISPECIMEN INC (ISPC) currently has 53 employees.


What are the support and resistance levels for ISPECIMEN INC (ISPC) stock?

ISPECIMEN INC (ISPC) has a resistance level at 1.89. Check the full technical report for a detailed analysis of ISPC support and resistance levels.


Is ISPECIMEN INC (ISPC) expected to grow?

The Revenue of ISPECIMEN INC (ISPC) is expected to grow by 6.58% in the next year. Check the estimates tab for more information on the ISPC EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ISPECIMEN INC (ISPC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ISPECIMEN INC (ISPC) stock pay dividends?

ISPC does not pay a dividend.


What is the Price/Earnings (PE) ratio of ISPECIMEN INC (ISPC)?

ISPECIMEN INC (ISPC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-18.7).


What is the Short Interest ratio of ISPECIMEN INC (ISPC) stock?

The outstanding short interest for ISPECIMEN INC (ISPC) is 4.73% of its float. Check the ownership tab for more information on the ISPC short interest.


ISPC Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ISPC Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ISPC. The financial health of ISPC is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ISPC Financial Highlights

Over the last trailing twelve months ISPC reported a non-GAAP Earnings per Share(EPS) of -18.7. The EPS increased by 17.26% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -84.55%
ROE -202.01%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%54.35%
Sales Q2Q%-4.24%
EPS 1Y (TTM)17.26%
Revenue 1Y (TTM)0.69%

ISPC Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to ISPC. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 96.29% and a revenue growth 6.58% for ISPC


Ownership
Inst Owners2.44%
Ins Owners14.3%
Short Float %4.73%
Short Ratio0.06
Analysts
Analysts82.86
Price TargetN/A
EPS Next Y96.29%
Revenue Next Year6.58%